Perfect Medical Announces Interim Results for FY2023/24

Nov 26, 2023 | Business

Perfect Medical Health Management Limited (the “Company”, Stock Code: 1830.HK), one of the largest aesthetic medical operators in the world, together with its subsidiaries (collectively referred to the “Group”), is pleased to announce its interim results for the six months ended 30 September 2023.

RESULTS HIGHLIGHTS

— The Group’s revenue increased by 7.5% to HK$718.1 million, thanks to the momentum growth in revenue in Hong Kong and mainland China amid the abatement of the pandemic in early 2023.

— The Group’s EBITDA increased by 5.4% to HK$242.1 million.

— The Group’s net profit increased by 10.4% to HK$166.4 million, representing a net profit margin of 23.2%. Basic earnings per share were HK13.2 cents. If excluding the one-off government subsidies in the last financial period, the adjusted net profit after tax increased by 27.1%.

— The Board recommends the payment of an interim dividend of HK13.2 cents and a special dividend of HK1.0 cents per share to shareholders.

— The Group operated a total service area of 297,000 square feet in Hong Kong, mainland China, Macau, Australia and Singapore, with an addition of two shops in Hong Kong during the period.

For the period under review, the Group achieved satisfactory results thanks to the meaningful return of new customers and the solid relationship with the loyal customers in both Hong Kong and mainland China. The Group’s revenue increased by 7.5% year-on-year to HK$718.1 million (FY2022/23 interim: HK$668.3 million). The Group’s EBITDA increased by 5.4% year-on-year to HK$242.1 million (FY2022/23 interim: HK$229.7 million). Profit attributable to equity holders of the Company was HK$166.4 million, increased by 10.4% year-on-year (FY2022/23 interim: HK$150.7 million), representing an increase of 0.7 percentage points in net profit margin to 23.2% for the period (FY2022/23 interim: 22.5%). Basic earnings per share were HK13.2 cents (FY2022/23 interim: HK12.1 cents).

As of 30 September 2023, the Group operated a total service area of 297,000 square feet in Hong Kong, mainland China and overseas.

Hong Kong Operation

Revenue from Hong Kong operation increased by 11.6% year-on-year to HK$549.6 million (FY2022/23 interim: HK$492.4 million), overtaking the revenue of Hong Kong operation before pandemic in FY2019/20 interim by 7.2%, thanks to the improvement in shop utilisation and the contribution from the newly established residential shops in Hong Kong. The recovery of revenue to beyond the FY2019/20 interim level demonstrates the Group’s success in recalibrating its business operation. Currently, revenue from Hong Kong operation accounted for 76.5% of the Group’s revenue (FY2022/23 interim: 73.7%).

As of 30 September 2023, the Group had a well-established network of service centres in Hong Kong covering a total service area of 192,000 square feet, with an increase of two shops in Tsuen Wan and Taikoo during the period.

During the period, the Group witnessed a strong demand for its core aesthetic medical services thanks to the unwavering support by its loyal customers. The Group has recalibrated its business model to further expand its geographical reach in Hong Kong through the introduction of residential shops in medium-to-high end shopping malls and residential locations. As for the core mega shops, the Group saw a welcoming response to the medical tourism flagship centres in Causeway Bay and Tsim Sha Tsui where there was intense demand for its premium medical beauty services by the cross-border customers.

At its non-aesthetic medical business, it includes a range of supplementary healthcare management services, including hair growth treatment, pain treatment, health screening service as well as other beauty and wellness services, to fully collaborate with our aesthetic medical services. During the period, the Group enhanced the cross-selling to the medical business following the improvement in our aesthetic medical business.

Regions outside Hong Kong

Revenue from regions outside Hong Kong decreased by 4.2% year-on-year to HK$168.5 million (FY2022/23 interim: HK$175.9 million), impacted by the lower demand in Singapore and Australia but compensated by the recovery in mainland China. Currently, revenue from the regions outside Hong Kong accounted for 23.5% of the Group’s revenue (FY2022/23 interim: 26.3%).

For the period under review, operating profit in mainland China and Macau improved year-on-year thanks to the gradual recovery in customers’ demand and the absence of business suspension in this financial period. As of 30 September 2023, the Group had a network of 22 shops in strategic locations in mainland China and Macau. In the first half of this financial year, the performance of the Australia and Singapore operation was impacted by the sustained inflationary environment and the high living expenses in both countries. It may take some time for the international market to recover.

Prospects

Dr. Au-Yeung Kong, the executive director, chairman and chief executive officer of Perfect Medical, said that “The promising business performance in the first half of the financial year has demonstrated our superior business model can withstand poor market conditions. We remained steadfast in our core strategy of ‘Healthcare + Medical Beauty’ to satisfy the individual needs of the consumers.

As the demand generally bounced back after the three-year pandemic, the rebound in tourist arrivals in Hong Kong this year will bring along additional cross-border customers to the Group, which will reinforce the Group’s determination to become the most favourable aesthetic medical service centres in the Greater Bay Area in the long run.

In mainland China, we will closely monitor the market dynamics and economic landscape to better prepare for the economic fluctuation. We spare no effort in optimising our business operation to improve shop productivity to fully capitalise on the rebound in foot traffic at shopping malls. As for the international market, we will proceed with its business development in a prudent and steady manner with relentless dedication to customer satisfaction.”

For further information of the Group’s FY2023/24 interim results, please refer to the Company’s Interim Results Announcement on the Hong Kong Stock Exchange website at: https://www1.hkexnews.hk/listedco/listconews/sehk/2023/1124/2023112400233.pdf

About Perfect Medical Health Management Limited

Perfect Medical Health Management Limited is a multinational aesthetic medical corporate and one of the largest aesthetic medical operators in the world established in 2003. The Group focuses primarily on non-invasive aesthetic medical services and medical services in Hong Kong, China, Macau, Australia and Singapore with a total service area spanning approximately 297,000 square feet as of 30 September 2023. Its operation offers a broad spectrum of professional services with assurance of utmost safety and efficacy. The Company was included as a constituent stock of the MSCI Hong Kong Small Cap Index on 27 May 2021, demonstrating the confidence from the capital market and recognising the investment value of the Company.

For further information, please contact:

Perfect Medical Health Management Limited

Marco So / Peter Kwok

Email: ir@perfectmedical.com

Tel: (852) 2770 2099

iPR Ogilvy Limited

Callis Lau / Tina Law / Rita Chen

Email: perfectmedical@iprogilvy.com

Tel: (852) 2136 6185


Topic: Press release summary

The Perfect Shipping Company Launches SEND, 1st Multicarrier Self-Service Shipping Kiosks

Mar 8, 2023 | Business

 The Perfect Shipping LLC is a leading packaging shipping solutions company in the United States. The company, in an effort to improve customer experience (waiting time, shipping process, surcharge errors) when shipping goods as well as optimize shipping high fixed costs, employee turnover and retention for shipping and receiving and supply chain companies, as well as university mail rooms, trade show shipping and hospitality business centers, Amazon and e-comm sellers and independent retail shipping stores, launches SEND (TM), offering the first self-service kiosks for global shipping that is carrier agnostic and operate as Shipping as a Service.

The company introduces customized packaging solutions to almost all types of shippers and packaging, offering low operation maintenance cost; contactless, secure, interactive user-friendly experience; mobile app integration and operation; loyalty and promotional discounts including an advertising option; and it’s all made in the USA.

“We are extremely proud to announce the initiation of our revolutionary service that can significantly lower operation costs while increasing profits for all shipping & receiving supply chain companies. Our company just launched a full line of Send kiosk. What makes our self-serving kiosk the ideal product is that it will reach new markets and increase locations closer to the consumer, optimizing costs and customer experience,” said The Perfect Shipping founder and CEO during a recent launch event.

For more information about The Perfect Shipping “SEND (TM)” line of solutions and its packaging solutions, visit the website at https://www.theperfectshipping.com.

Contact

The Perfect Shipping LLC
Luis Ortiz
(786) 265–9418
https://www.theperfectshipping.com
The leading self-service shipping kiosks company in USA.

The Perfect Shipping LLC
Jaime Rubinstein
786-265-9418
www.theperfectshipping.com

ContactContact

Categories

  • Business
  • Logistics

Dale Hurteau a “Perfect Fit” for Guardian Data Destruction’s New Client Success Manager Role

Feb 18, 2023 | Books, Business

Growth of onsite data destruction services, enterprise services, corporate ESG goals and data center services leads to new position

SOUTH HACKENSACK, N.J. – Feb. 16, 2023 – PRLog — Guardian Data Destruction announced today that current Enterprise Services Manager Dale Hurteau is the optimal internal talent to fill the newly-created, high-level position of Client Success Manager. In this new capacity, Hurteau will be responsible for working one-on-one with ITADs, VARs, resellers and MSPs to design and scope optimal IT data destruction and data center solutions that protect customer data security and privacy.

Since returning to Guardian Data Destruction in 2021, Hurteau has served as the Enterprise Services Manager. As such, he focused on managing project scope and onsite processes for complex, large-scale North American enterprise data center projects including erasure, decommissioning, lift and shift, and secure IT transit.

Hurteau’s ITAD experiences began with a job developing IT asset disposition solutions for Fortune 500 companies. In 2001, Dale solved a telecom client’s problem while launching what was to become Guardian Data Destruction. Dale went on to form an ITAD company focused on data centers. After 10+ successful years, Dale returned to Guardian to manage the company’s Enterprise Data Center projects.

Glenn Laga, Guardian President and Founder, couldn’t be happier with the growth-related position and Hurteau’s new role, “Requests for a higher level of enterprise services are on the rise. These projects require a sophisticated level of technical data center knowledge including cable mapping, highly sensitive networks and servers, equipment migration, hybrid data destruction planning and hyper-scale enterprise erasure. We were thrilled to have Dale rejoin the Guardian team two years ago. Dale’s new role as a Client Success Manager will allow customers to use his enterprise knowledge to create secure, single-source, end-to-end solutions. I see this as a tremendous advantage for our ITAD partners and their clients who do not have the expertise or bandwidth to manage multiple service providers for large IT or data center projects.”

As a subject matter expert with almost forty years of hands-on field experience, Hurteau is a best practices resource to Guardian customers and the company’s internal service divisions. By bridging services and deliverables from Data Destruction Services, IT Packing and Logistics and Enterprise Data Center Services, his goal is to grow company sales and customer satisfaction.

Dale Hurteau can be contacted at 248-417-1755 and  dhurteau@guardiandatadestruction.com. He will be an expert speaker at 2023 trade shows and conferences including i-SIGMA, IAITAM, Datacom World and ITAD Summit.

###

About Guardian Data Destruction

Guardian Data Destruction is an onsite, single-source solution for data center decommissioning, data destruction and packing and logistics services. Guardian eliminates the risk of even a single data breach that could arise during the transport of hard drives and computer equipment by bringing its nationwide fleet of trucks and skilled technicians directly to a facility to erase, shred, decommission, pack or transfer IT assets. With over 19 million media devices protected, Guardian Data Destruction is the leader in providing absolute data compliance and security. Guardian Data Destruction is a privately held New Jersey-based company. Please go to www.GuardianDataDestruction.com for more information. (https://www.guardiandatadestruction.com/)

Perfect Medical’s Major Shareholders Further Increase along with Company Buybacks, Strong Confidence in the Future Prospects

Aug 1, 2022 | Business

Perfect Medical Health Management Limited (“Perfect Medical” or the “Company”, the “Group”; Stock code: 1830.HK), one of the largest medical groups in Hong Kong, together with its subsidiaries (collectively referred to as the “Group”), is pleased to announce that on the 4th and 5th July 2022, Dr. Au-Yeung Kong, the executive director, chairman and chief executive officer of the Group (“Dr. Au-Yeung”) further purchase a total of 7,5000,000 shares of the Company, for an aggregate consideration of HK$30.675 million. Following the further purchase, Dr. Au-Yeung is interested in an aggregate of 909,287,383 shares and his equity stake increased from 72.92% to 73.33%. At the same time, on the 4th of July 2022, the Company repurchased 1,000,000 shares for an aggregate consideration of HK$3.978 million under the Repurchase Mandate, representing approximately 0.08% of the issued share capital.

The Company announced its FY2021/22 annual results in late June. The Company achieved a historical high revenue of HK$1.35 billion, representing a growth of 23.9% despite the impact of the pandemic. The Company achieved a net profit of HK$305.2 million. If excluding the government subsidies in both years, the revised net profit for the Group increased by 29.8%. With a solid financial position, actively seeking mergers and acquisitions of medical projects and global expansion strategies, the Company will deliver sustainable growth in the long run.

Dr. Au-Yeung, said that “the further purchase demonstrates the confidence about the future prospects of the Company and is optimistic about the Company’s future development and may consider further increasing the shareholding in the Company when appropriate in the future. With the weakening of the impact of the pandemic, the Company is well-positioned to capitalize on the market opportunities and respond to the rebound of customers’ demand in the post-pandemic era. In the future, the Company will gear up its effort organically, actively seek mergers and acquisitions of medical projects, and make optimization and integration to offer additional high-quality services to our customers. Looking ahead, the Company will increase the proportion of medical services and proceed with the international business expansion, with a view to becoming a truly multinational medical group.”

About Perfect Medical Health Management Limited
Perfect Medical Health Management Limited is a multinational aesthetic medical corporate and one of the largest aesthetic medical companies in Hong Kong established in 2003. The Group focuses primarily on non-invasive aesthetic medical services and medical services in Hong Kong, China, Macau, Australia and Singapore with a total service area spanning approximately 322,000 square feet. Our operation offers a broad spectrum of professional services with assurance of utmost safety and efficacy. The Company was included as a constituent stock of the MSCI Hong Kong Small Cap Index on 27 May 2021, demonstrating the confidence of the capital market and recognizing the investment value of the Company.






Topic: Press release summary

Sectors: Healthcare & Pharm


http://www.acnnewswire.com

From the Asia Corporate News Network

Copyright © 2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.








Perfect Medical Announces Final Results for FY2021/22

Jul 5, 2022 | Business

Perfect Medical Health Management Limited (“Perfect Medical” or the “Company”, stock code: 1830.HK), one of the largest medical groups in Hong Kong, together with its subsidiaries (collectively referred to as the “Group”), is pleased to announce its annual results for the year ended 31 March 2022.

Performance highlights
— The Company achieved a historical high revenue of HK$1.35 billion, representing a growth of 23.9%.
— Among the value of sales contract, aesthetic medical accounted for 66.0%, medical business accounted for 17.4% and beauty and wellness accounted for 16.6%.
— The Company achieved a satisfactory net profit of HK$305.2 million despite the impact of the pandemic. If excluding the government subsidies, the revised net profit after tax increased by 29.8%.
— The Company has expanded its geographical coverage to Hong Kong, China, Australia and Singapore, representing total service area increased by 39.0% to 322,000 sq.ft..
— Basic earnings per share increased by 2.1% to HK24.8 cents.
— To reward the shareholders’ unwavering support, the Board recommended the payment of a final dividend of HK7.1 cents per share. Together with the interim dividend of HK17.7 cents per share, the total dividend per share is expected to be HK24.8 cents per share for the full year, representing a total dividend payout ratio of 100.0%.

For the year under review, the Group’s revenue increased by 23.9% to HK$1,350.0 million (FY2021: HK$1,089.8 million). The Group’s EBITDA increased by 11.5% to HK$469.5 million (FY2021: HK$421.0 million). Profit attributable to shareholders of the Company was HK$305.2 million (FY2021: HK$284.6 million), representing a year-on-year increase of 7.2%, and a net profit margin of 22.6% (FY2021: 26.1%).

During the year, the Group has geared up its service centre expansion pace in Hong Kong, China and overseas. Currently, the Group has expanded its penetration in strategic locations at office premises and shopping malls, with total GFA increasing by 39% to 322,000 square feet.

Hong Kong Operation

Revenue from Hong Kong Operation increased by 43.6% to HK$975.1 million (FY2021: HK$679.0 million), mainly attributable to revenue contribution in the aesthetic medical and medical businesses as well as the additional revenue contributed from the new service centres established in the past years, but offset by the closure of all service centres for 84 days since January 2022 owing to the Omicron outbreak. Currently, the Group has a well established network of service centres in Hong Kong covering a total of 198,000 square feet.

The Company is mainly engaged in the operation of aesthetic medical and medical service in Hong Kong. From September to November 2021, the Company opened three service centres in Tsim Sha Tsui, Shatin and Central to consolidate its leading position in Hong Kong medical market.

In terms of the medical service business, leveraging on the strong foundation in the aesthetic medical business in Hong Kong, the Group has consistently reviewed its service portfolio through providing additional value-added services to enhance the customers’ stickiness. In addition, the Group has made subsequent investments in a range of medical services to boost cross-selling and lower the acquisition cost of the customers.

Regions outside Hong Kong

Revenue from regions outside Hong Kong decreased by 8.8% to HK$374.8 million (FY2021: HK$410.8 million) due to the poor market sentiment and the continual lockdown under the pandemic. As of 31 March 2022, the Company has an extensive network in China, Macau, Sydney, Melbourne and Singapore, covering a gross service area of 124,000 square feet.

As one of the pioneers in the aesthetic medical industry in China, the Group has been focusing on key coastal first tier cities in Southern and Eastern China as well as the country’s capital in Beijing, in order to cultivate a premium branding image. With the escalating customers’ demand on a more all-round and professional medical services, the Group hopes to foster a stronger operation loop and a synergy to better serve our customers.

Prospects

Dr. Au-Yeung Kong, the executive director, chairman and chief executive officer of Perfect Medical, said that “This year marks the 11th anniversary of the Company’s listing on the Stock Exchange of Hong Kong Limited since 10 February 2012. Our business covers Hong Kong, China, Macau, Australia and Singapore. At present, the Company has built a one-stop service platform incorporating a comprehensive aesthetic medical and medical services, fully catered to customers’ needs.

With the weakening of the impact of the pandemic, the Company is well positioned to capitalize on the market opportunities and respond to the rebound of customers’ demand in the post-pandemic era. In the future, the Company will gear up its effort organically, actively seek mergers and acquisitions of medical projects, and make optimisation and integration to offer additional high-quality services to our customers.

Looking ahead, the Company will increase the proportion of medical services and proceed with the international business expansion, with a view to becoming a truly multinational medical group.

For further information on the Group’s FY2021/22 annual results, please refer to the Company’s annual results announcement on the website of the Hong Kong Stock Exchange.

https://www1.hkexnews.hk/listedco/listconews/sehk/2022/0630/2022063000866.pdf

About Perfect Medical Health Management Limited
Perfect Medical Health Management Limited is a multinational aesthetic medical corporate and one of the largest aesthetic medical companies in Hong Kong established in 2003. The Group focuses primarily on non-invasive aesthetic medical services and medical services in Hong Kong, China, Macau, Australia and Singapore with a total service area spanning approximately 322,000 square feet. Our operation offers a broad spectrum of professional services with assurance of utmost safety and efficacy. The Company was included as a constituent stock of the MSCI Hong Kong Small Cap Index on 27 May 2021, demonstrating the confidence from the capital market and recognising the investment value of the Company.






Topic: Press release summary

Sectors: Healthcare & Pharm


http://www.acnnewswire.com

From the Asia Corporate News Network

Copyright © 2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.